Utilization of Prognostic Biomarker Soluble Urokinase Plasminogen Activator Receptor in the Emergency Department: A Tool for Safe and More Efficient Decision-making.

Ria M HolsteinMarja T MäkinenMaaret K CastrénJohanna M Kaartinen

Published in: Biomarker insights (2022)

The utilization of suPAR did not increase the risk for neither positive nor negative outcomes. Low suPAR values could be potential in discharging more patients safely. Instead of unselected patient populations, the benefits of suPAR measurements in the ED could emerge in the assessment of a more precisely determined and selected group of patients.

Keyphrases

emergency department
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
adipose tissue
patient reported outcomes
climate change
glycemic control